Liquidia Co. (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 2,260 shares of the company's stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $11.11, for a total transaction of $25,108.60. Following the completion of the sale, the insider now directly owns 207,383 shares of the company's stock, valued at $2,304,025.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Rajeev Saggar also recently made the following trade(s):
- On Friday, July 19th, Rajeev Saggar sold 1,873 shares of Liquidia stock. The shares were sold at an average price of $11.13, for a total value of $20,846.49.
Liquidia Stock Up 2.2 %
Shares of LQDA opened at $11.38 on Wednesday. Liquidia Co. has a 52-week low of $5.71 and a 52-week high of $16.99. The company has a 50-day simple moving average of $10.40 and a 200-day simple moving average of $11.97. The company has a market capitalization of $869.59 million, a PE ratio of -7.29 and a beta of 0.22.
Liquidia (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.02). The company had revenue of $3.66 million during the quarter, compared to analysts' expectations of $7.92 million. Liquidia had a negative net margin of 755.46% and a negative return on equity of 183.57%. On average, research analysts anticipate that Liquidia Co. will post -1.69 EPS for the current year.
Hedge Funds Weigh In On Liquidia
Urgent: This election is rigged
From Porter & Company | Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System grew its holdings in Liquidia by 491.2% in the first quarter. California State Teachers Retirement System now owns 46,181 shares of the company's stock valued at $681,000 after purchasing an additional 38,369 shares during the last quarter. BNP Paribas Financial Markets grew its stake in Liquidia by 119.4% in the 1st quarter. BNP Paribas Financial Markets now owns 230,248 shares of the company's stock valued at $3,396,000 after acquiring an additional 125,315 shares during the last quarter. Swiss National Bank purchased a new position in Liquidia during the 1st quarter valued at about $1,325,000. Boston Partners purchased a new position in Liquidia during the 1st quarter valued at about $762,000. Finally, Principal Financial Group Inc. raised its position in Liquidia by 112.3% during the first quarter. Principal Financial Group Inc. now owns 36,462 shares of the company's stock worth $538,000 after acquiring an additional 19,288 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have weighed in on LQDA. HC Wainwright lowered their target price on Liquidia from $32.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, August 20th. Lifesci Capital started coverage on shares of Liquidia in a research report on Thursday, October 3rd. They issued an "outperform" rating and a $30.00 price objective on the stock. BTIG Research cut their price objective on shares of Liquidia from $29.00 to $25.00 and set a "buy" rating for the company in a research report on Monday, August 19th. Bank of America lowered their target price on shares of Liquidia from $24.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, August 20th. Finally, Needham & Company LLC reissued a "buy" rating and set a $25.00 price target on shares of Liquidia in a report on Monday, August 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $24.00.
Check Out Our Latest Analysis on LQDA
Liquidia Company Profile
(
Get Free Report)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
